搜索结果: 1-11 共查到“性医学 man”相关记录11条 . 查询时间(0.119 秒)
An uncommon subtype of breast carcinoma in a man: The pure mucinous carcinoma
Mucinous carcinoma male breast carcinoma pure mucinous type prognosis
2015/7/21
Aim: Our purpose is to describe a new case of pure mucinous carcinoma in a man, to put emphasis on the rarity of this histologic subtype and the problems of management due to the fewer reported cases ...
Previously spermatozoa in the semen of vasectomized men were reported in 62 of 63 specimens from 24 men 2 to 31 years postvasectomy (Freund and Couture, 1982). A morphologic basis and term, "microreca...
Serum testosterone response to desialylated human choriogonadotropin in man
Serum testosterone desialylated human choriogonadotropin man
2009/2/23
To assess the in vivo steroidogenic activity of desialylated human choriogonadotropin (hCG) in man, highly purified desialylated hCG was administered as a constant intravenous infusion over 6 hours ...
Induced hypoprolactinemia and testicular steroidogenesis in man
prolactin testes bromocriptine androgens
2009/2/20
The effects of short-term hypoprolactinemia on the pituitary-gonadal axis were evaluated in a group of patients with untreated prostatic carcinoma. Each patient was studied prior to and during 7-day...
The effect of testicular x-irradiation on spermatogenesis in man. A comparison with the mouse
irradiation spermatogenesis testicular
2009/2/20
Existing data concerning the effects of x-irradiation on spermatogenesis in man were analyzed and the results were compared to published data on the mouse. Testicular x-irradiation produced a transi...
Combined treatment with an LHRH agonist and testosterone in man. Reversible oligozoospermia without impotence
LHRH (GnRH) testosterone spermatogenesis
2009/2/19
We have previously shown that LHRH agonist [D-Trp6,Pro9-NEt]LHRH (LHRHA) results in reversible oligozoospermia when given to normal subjects for up to ten weeks. A fall in plasma testosterone was ac...
Acute hormonal changes following chemotherapy for Hodgkin's disease in man
Acute hormonal changes Hodgkin's disease man
2009/2/19
Eleven men, aged 21 to 60 years, with Hodgkin's disease have been studied before, during, and after chemotherapy. Blood samples were obtained for hormone analyses. In all 11 patients FSH levels rose...
Retained Undescended Testis in a 51-Year-old“Anorchic”Man: The Implications of Endocrine Evaluation in the Adult Male With Impalpable Testes
Retained Undescended Testis 51-Year-old "Anorchic" Man Implications Endocrine Evaluation
2009/2/19
A 51-year-old man with previously diagnosed bilateral anorchia was shown by endocrine investigation of his hypophyseal-gonadal axis to have functioning testicular tissue. The implications of endocri...
Competition of the Histamine H2 Antagonist Cimetidine for Androgen Binding Sites in Man
cimetidine androgen binding prostate testis
2009/2/18
Gynecomastia and impotence have been described as side-effects of cimetidine therapy. It has previously been shown that cimetidine possesses antiandrogenic properties and competes for dihydrotesto...
Distribution and tissue expression of semenogelin I and II in man as demonstrated by in situ hybridization and immunocytochemistry
Semen spermatozoa fertilization Southern blot
2009/2/16
Semenogelin I and II (Sgl, Sgll) are two separate gene products of chromosome 20 with extensive (80%) identity in primary structure. They are mainly responsible for immediate gel formation of fres...
Comparative effects of two different delivery systems on gonadotropin-releasing hormone（GnRH） antagonist-induced suppression of gonadotropins and testosterone in man
GnRH antagonists luteinizing hormone (LH)
2009/2/12
The Nal-Glu gonadotropin-releasing hormone (GnRH) antagonist, when given in daily subcutaneous (SC) doses of 5 mg or higher, maximally suppresses serum luteinizing hormone (LH) and follicle-stimul...